P-047: PROSPECTIVE IDENTIFICATION OF VARIABLES AS OUTCOMES FOR TREATMENT (PIVOT): A PHASE II CLINICAL TRIAL OF HYDROXYUREA FOR CHILDREN AND ADULTS WITH HBSC DISEASE
SMART L.,
SEGBEFIA C.,
LATHAM T.,
STUBER S.,
AMISSAH-ARTHUR K.,
LANE A.,
DEI-ADOMAKOH Y.,
WARE R.
Affiliations
SMART L.
1 Cincinnati Children’s Hospital Medical Center Division of Hematology, Cincinnati, UNITED STATES
SEGBEFIA C.
4 University of Ghana Medical School Department of Child Health, Accra, GHANA
LATHAM T.
1 Cincinnati Children’s Hospital Medical Center Division of Hematology, Cincinnati, UNITED STATES
STUBER S.
1 Cincinnati Children’s Hospital Medical Center Division of Hematology, Cincinnati, UNITED STATES
AMISSAH-ARTHUR K.
6 University of Ghana Medical School Ophthalmology Unit Department of Surgery, Accra, GHANA
LANE A.
1 Cincinnati Children’s Hospital Medical Center Division of Hematology, Cincinnati, UNITED STATES
DEI-ADOMAKOH Y.
8 University of Ghana Medical School Department Haematology, Accra, GHANA
WARE R.
1 Cincinnati Children’s Hospital Medical Center Division of Hematology, Cincinnati, UNITED STATES
